BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 12649174)

  • 1. Is the p53 inactivation frequency in squamous cell carcinomas of the head and neck underestimated? Analysis of p53 exons 2-11 and human papillomavirus 16/18 E6 transcripts in 123 unselected tumor specimens.
    Balz V; Scheckenbach K; Götte K; Bockmühl U; Petersen I; Bier H
    Cancer Res; 2003 Mar; 63(6):1188-91. PubMed ID: 12649174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The ATM/p53 pathway is commonly targeted for inactivation in squamous cell carcinoma of the head and neck (SCCHN) by multiple molecular mechanisms.
    Bolt J; Vo QN; Kim WJ; McWhorter AJ; Thomson J; Hagensee ME; Friedlander P; Brown KD; Gilbert J
    Oral Oncol; 2005 Nov; 41(10):1013-20. PubMed ID: 16139561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of human papillomavirus-16 infection on CD8+ T-cell recognition of a wild-type sequence p53264-272 peptide in patients with squamous cell carcinoma of the head and neck.
    Sirianni N; Ha PK; Oelke M; Califano J; Gooding W; Westra W; Whiteside TL; Koch WM; Schneck JP; DeLeo A; Ferris RL
    Clin Cancer Res; 2004 Oct; 10(20):6929-37. PubMed ID: 15501971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human papillomavirus and p53 mutational status as prognostic factors in head and neck carcinoma.
    Sisk EA; Soltys SG; Zhu S; Fisher SG; Carey TE; Bradford CR
    Head Neck; 2002 Sep; 24(9):841-9. PubMed ID: 12211048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p53 codon 72 polymorphic variants, loss of allele-specific transcription, and human papilloma virus 16 and/or 18 E6 messenger RNA expression in squamous cell carcinomas of the head and neck.
    Scheckenbach K; Lieven O; Götte K; Bockmühl U; Zotz R; Bier H; Balz V
    Cancer Epidemiol Biomarkers Prev; 2004 Nov; 13(11 Pt 1):1805-9. PubMed ID: 15533911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p53 alterations in recurrent squamous cell cancer of the head and neck refractory to radiotherapy.
    Ganly I; Soutar DS; Brown R; Kaye SB
    Br J Cancer; 2000 Jan; 82(2):392-8. PubMed ID: 10646894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inverse relationship between human papillomavirus-16 infection and disruptive p53 gene mutations in squamous cell carcinoma of the head and neck.
    Westra WH; Taube JM; Poeta ML; Begum S; Sidransky D; Koch WM
    Clin Cancer Res; 2008 Jan; 14(2):366-9. PubMed ID: 18223210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reliable detection of p53 aberrations in squamous cell carcinomas of the head and neck requires transcript analysis of the entire coding region.
    Hauser U; Balz V; Carey TE; Grénman R; Van Lierop A; Scheckenbach K; Bier H
    Head Neck; 2002 Sep; 24(9):868-73. PubMed ID: 12211051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human papillomavirus type 16 E6 and E7 genotypes in head-and-neck carcinomas.
    Hoffmann M; Lohrey C; Hunziker A; Kahn T; Schwarz E
    Oral Oncol; 2004 May; 40(5):520-4. PubMed ID: 15006625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. E6 and e7 gene silencing and transformed phenotype of human papillomavirus 16-positive oropharyngeal cancer cells.
    Rampias T; Sasaki C; Weinberger P; Psyrri A
    J Natl Cancer Inst; 2009 Mar; 101(6):412-23. PubMed ID: 19276448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human papillomavirus type 16 in head and neck carcinogenesis.
    Chen R; Aaltonen LM; Vaheri A
    Rev Med Virol; 2005; 15(6):351-63. PubMed ID: 15942978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genome-wide DNA copy number alterations in head and neck squamous cell carcinomas with or without oncogene-expressing human papillomavirus.
    Smeets SJ; Braakhuis BJ; Abbas S; Snijders PJ; Ylstra B; van de Wiel MA; Meijer GA; Leemans CR; Brakenhoff RH
    Oncogene; 2006 Apr; 25(17):2558-64. PubMed ID: 16314836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of human papillomavirus prevalence and TP53 polymorphism in head and neck squamous cell carcinomas.
    Cortezzi SS; Provazzi PJ; Sobrinho JS; Mann-Prado JC; Reis PM; de Freitas SE; Filho JF; Fukuyama EE; Cordeiro JA; Cury PM; Maniglia JV; Villa LL; Tajara EH; Rahal P
    Cancer Genet Cytogenet; 2004 Apr; 150(1):44-9. PubMed ID: 15041222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutation of p53 in head and neck squamous cell carcinoma correlates with Bcl-2 expression and increased susceptibility to cisplatin-induced apoptosis.
    Andrews GA; Xi S; Pomerantz RG; Lin CJ; Gooding WE; Wentzel AL; Wu L; Sidransky D; Grandis JR
    Head Neck; 2004 Oct; 26(10):870-7. PubMed ID: 15390206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human papillomavirus-16 associated squamous cell carcinoma of the head and neck (SCCHN): a natural disease model provides insights into viral carcinogenesis.
    Ferris RL; Martinez I; Sirianni N; Wang J; López-Albaitero A; Gollin SM; Johnson JT; Khan S
    Eur J Cancer; 2005 Mar; 41(5):807-15. PubMed ID: 15763658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of intact HPV16 E6/E7 gene expression in head and neck cancers with unaltered p53 status and perturbed pRb cell cycle control.
    Wiest T; Schwarz E; Enders C; Flechtenmacher C; Bosch FX
    Oncogene; 2002 Feb; 21(10):1510-7. PubMed ID: 11896579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequent deletion and down-regulation of ING4, a candidate tumor suppressor gene at 12p13, in head and neck squamous cell carcinomas.
    Gunduz M; Nagatsuka H; Demircan K; Gunduz E; Cengiz B; Ouchida M; Tsujigiwa H; Yamachika E; Fukushima K; Beder L; Hirohata S; Ninomiya Y; Nishizaki K; Shimizu K; Nagai N
    Gene; 2005 Aug; 356():109-17. PubMed ID: 15935570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mapping and analysis of HPV16 integration sites in a head and neck cancer cell line.
    Ragin CC; Reshmi SC; Gollin SM
    Int J Cancer; 2004 Jul; 110(5):701-9. PubMed ID: 15146560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alterations of the p16 gene in head and neck cancer: frequency and association with p53, PRAD-1 and HPV.
    Olshan AF; Weissler MC; Pei H; Conway K; Anderson S; Fried DB; Yarbrough WG
    Oncogene; 1997 Feb; 14(7):811-8. PubMed ID: 9047388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Status of the p53 tumor suppressor gene in human squamous carcinoma cell lines.
    Reiss M; Brash DE; Muñoz-Antonia T; Simon JA; Ziegler A; Vellucci VF; Zhou ZL
    Oncol Res; 1992; 4(8-9):349-57. PubMed ID: 1486218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.